A drug to treat cocaine addiction?

Structure of cocaine

Structure of cocaine (Photo credit: Wikipedia)

A recent study on the use of topiramate for cocaine addiction has been getting a lot of attention. Most of the coverage draws only from the researchers press release.

“Using an intent-to-treat analysis, the researchers found that topiramate was more efficacious than placebo at increasing the participants’ weekly proportion of cocaine nonuse days and in increasing the likelihood that participants would have cocaine-free weeks,” the university said Friday in a statement.

Similarly, Johnson’s team found a significant association between topiramate and both a decrease in craving for the drug and an improvement in the subjects’ overall level of functioning in comparison to a placebo.

Here are a few things you should know.

  1. What does “more efficacious than placebo” mean? It means that the number of days subjects did not use cocaine increased to 13.3% or 8.9%. (Depending on how you calculate it.) So, subjects still used cocaine 86.7% or 91.1% of days.
  2.  There a history of concerns about the manufacturer of the drug promoting off-label use of the drug.
  3. The lead researcher left his last post after losing a whistleblower lawsuit. One of his projects had been accused improperly charging the federal government for time spent on a study. He also attacked the character of the whistleblower.
  4. The lead researcher has a financial interest in topiramate.

I’m sure we’ll come up with effective drugs some day, but I’m skeptical that this is one of them.

4 Comments

Filed under Research, Treatment

4 responses to “A drug to treat cocaine addiction?

  1. Replacement therapy does not work. Even where some efficacy can be demonstrated, it can also be construed as merely “enhancing” the primary adddiction. Behaviours, attitudes, do not alter in the patient, generally.

  2. Well, well, well. The devil is in the detail. Quite incredible how much of a spin can be put on a drug that seems to have such a small effect. Compare with your recent blog on the Litt paper on reduction in relapse by 27% simply with a behavioural intervention.

    • chuck gehrke

      Emphasizes again the great caution needed when interpreting any of the claims made by the pharmaceutical companies about the benefits of a drug new or old, on or off label.

  3. I’ve never been a fan of treating drug addiction with more drugs. And this topiramate is even associated with other major health concerns- apart from the four alarming points mentioned by you, Jason.